The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2009
Filed:
Jul. 23, 2003
Applicants:
Mark Ebden, Loughborough, GB;
Premji Meghani, Loughborough, GB;
Colin Bennion, Loughborough, GB;
Anthony Ronald Cook, Loughborough, GB;
Roger Victor Bonnert, Loughborough, GB;
Inventors:
Mark Ebden, Loughborough, GB;
Premji Meghani, Loughborough, GB;
Colin Bennion, Loughborough, GB;
Anthony Ronald Cook, Loughborough, GB;
Roger Victor Bonnert, Loughborough, GB;
Assignee:
AstraZeneca AB, , SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/46 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 407/12 (2006.01); C07D 407/14 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61P 11/06 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract
A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.